SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000905718-22-000349
Filing Date
2022-02-14
Accepted
2022-02-14 16:17:31
Documents
1
Group Members
ABINGWORTH BIOVENTURES VI, LP

Document Format Files

Seq Description Document Type Size
1 SC 13G/A vaxcyte_13gam1dec312021.htm SC 13G/A 60158
  Complete submission text file 0000905718-22-000349.txt   61747
Mailing Address 38 JERMYN STREET LONDON X0 SW1Y 6DN
Business Address 38 JERMYN STREET LONDON X0 SW1Y 6DN 44 (0)20 7534 1500
Abingworth LLP (Filed by) CIK: 0001397144 (see all company filings)

IRS No.: 980518585 | State of Incorp.: X0 | Fiscal Year End: 0630
Type: SC 13G/A

Mailing Address 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070
Business Address 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070 650-837-0111
Vaxcyte, Inc. (Subject) CIK: 0001649094 (see all company filings)

IRS No.: 464233385 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91543 | Film No.: 22632285
SIC: 2836 Biological Products, (No Diagnostic Substances)